Search - tctmd.com

Displaying 1 - 20 of 806

Sort: Relevancy | Date

Presentation TCT 2025

Two Stents at the Bifurcation: Tailoring Your Technique

Presenter: Kefei Dou

October 28, 2025

Presentation TCT 2025

Randomized Comparison of the Supraflex CruzTM vs. SYNERGYTM Drug-Eluting Stents: The Multivessel TALENT Randomized Trial

Presenter: Patrick W. Serruys

October 28, 2025

Presentation TCT 2025

TCT 891: Safety and clinical performance of the Yukon Choice PC, Yukon Chrome PC & Yukon Choice Flex Sirolimus Eluting Bioabsorbable Polymer Stents Systems in Routine Clinical Practice: e-Yukon Global Registry.

Presenter: Bimmer E. Claessen

October 28, 2025

Presentation TCT 2025

TCT 1023: Comparative Effectiveness of DES, DCB, and BMS for the Treatment of In-Stent Restenosis in Carotid Artery Stents: A Systematic Review and Meta-Analysis

Presenter: Mehmet Cilingiroglu

October 28, 2025

Presentation TCT 2025

TCT 1562: Proximal LAD Perforation During High-Risk LM-LAD PCI: Managing Covered Stents Without Compromising Main Branch Bifurcation

Presenter: Mo'ath Bani Ali

October 28, 2025

Presentation TCT 2025

Tuxedo-II trial : Supraflex Cruz vs Xience Family stents comparison

Presenter: Upendra Kaul

October 28, 2025

Presentation TCT 2025

TCT 1753: IVUS Guided LMCA True Bifurcation Medina 1,1,1 Double Kiss Crush Angioplasty and Two Stents to Mid Lad and Left Circumflex in Stage 5 Chronic Kidney Disease

Presenter: Binoy John

October 27, 2025

Presentation TCT 2025

TCT 468: Comparison of Limus and Paclitaxel Drug-Coated Balloons, 2nd-generation or Newer Drug-Eluting Stents, and Balloon Angioplasty: A Network Meta-Analysis of Randomized Controlled Trials

Presenter: Yuko Kiyohara

October 27, 2025

Presentation TCT 2025

TCT 430: Photon-Counting Detector Computed Tomography for the Assessment of Coronary Stents and In-Stent Restenosis

Presenter: Doosup Shin

October 27, 2025

Presentation TCT 2025

TCT 511: Paclitaxel-Coated Balloons versus Newer-Generation Drug-Eluting Stents for De Novo Coronary Artery Lesions: A Meta-Analysis of Randomized Controlled Trials

Presenter: Kamil Bujak

October 27, 2025

Presentation TCT 2025

TCT 502: Drug-Coated Balloons Versus Drug-Eluting Stents for Patients with Diffuse De Novo Coronary Artery Lesions: Insights from the REC-CAGEFREE I Trial

Presenter: Yuehao Lv

October 27, 2025

Presentation TCT 2025

TCT 503: Impact of sex on outcomes in patients treated with drug-coated balloons versus drug-eluting stents for de novo coronary artery lesions: Insights from the REC-CAGEFREE I trial

Presenter: Ping Wang

October 27, 2025

Presentation TCT 2025

TCT 500: Clinical Outcomes of Patients With ST-Elevation Myocardial Infarction Treated With Drug-coated Balloons, Hybrid Strategies, or Drug-eluting Stents

Presenter: Nancy Virginia

October 27, 2025

Presentation TCT 2025

TCT 1856: So Many Layers of Stents and an Aneurysm: What Can You Do?

Presenter: Elias Sanidas

October 27, 2025

Presentation TCT 2025

TCT 235: Efficacy of Bioresorbable Vascular Scaffold vs Drug-Eluting Stents After PCI : A GRADE-Assessed Systematic Review and Meta-Analysis of Randomised Controlled Trials

Presenter: Sultana Jahan

October 26, 2025

Presentation TCT 2025

Closing Thoughts

Presenter: Robert W. Yeh

October 26, 2025

Presentation TCT 2025

Case Discussion

Presenter: Robert W. Yeh

October 26, 2025

Presentation TCT 2025

Case Presentation: Outcomes with Bioadaptor in Complex PCI

Presenter: Tamil Selvan Muthusamy

October 26, 2025

Presentation TCT 2025

Case Presentation: Long-Term Follow Up in LAD Disease and Computational Analysis

Presenter: Daniela Benedetto

October 26, 2025

Presentation TCT 2025

Panel Discussion: Why Does the MOA of Bioadaptor Matter? Impact on Patients Outcomes in PCI

Presenter: Robert W. Yeh

October 26, 2025

Advertisement

Two Stents at the Bifurcation: Tailoring Your Technique

Randomized Comparison of the Supraflex CruzTM vs. SYNERGYTM Drug-Eluting Stents: The Multivessel TALENT Randomized Trial

TCT 891: Safety and clinical performance of the Yukon Choice PC, Yukon Chrome PC & Yukon Choice Flex Sirolimus Eluting Bioabsorbable Polymer Stents Systems in Routine Clinical Practice: e-Yukon Global Registry.

TCT 1023: Comparative Effectiveness of DES, DCB, and BMS for the Treatment of In-Stent Restenosis in Carotid Artery Stents: A Systematic Review and Meta-Analysis

TCT 1562: Proximal LAD Perforation During High-Risk LM-LAD PCI: Managing Covered Stents Without Compromising Main Branch Bifurcation

Tuxedo-II trial : Supraflex Cruz vs Xience Family stents comparison

TCT 1753: IVUS Guided LMCA True Bifurcation Medina 1,1,1 Double Kiss Crush Angioplasty and Two Stents to Mid Lad and Left Circumflex in Stage 5 Chronic Kidney Disease

TCT 468: Comparison of Limus and Paclitaxel Drug-Coated Balloons, 2nd-generation or Newer Drug-Eluting Stents, and Balloon Angioplasty: A Network Meta-Analysis of Randomized Controlled Trials

TCT 430: Photon-Counting Detector Computed Tomography for the Assessment of Coronary Stents and In-Stent Restenosis

TCT 511: Paclitaxel-Coated Balloons versus Newer-Generation Drug-Eluting Stents for De Novo Coronary Artery Lesions: A Meta-Analysis of Randomized Controlled Trials

TCT 502: Drug-Coated Balloons Versus Drug-Eluting Stents for Patients with Diffuse De Novo Coronary Artery Lesions: Insights from the REC-CAGEFREE I Trial

TCT 503: Impact of sex on outcomes in patients treated with drug-coated balloons versus drug-eluting stents for de novo coronary artery lesions: Insights from the REC-CAGEFREE I trial

TCT 500: Clinical Outcomes of Patients With ST-Elevation Myocardial Infarction Treated With Drug-coated Balloons, Hybrid Strategies, or Drug-eluting Stents

TCT 1856: So Many Layers of Stents and an Aneurysm: What Can You Do?

TCT 235: Efficacy of Bioresorbable Vascular Scaffold vs Drug-Eluting Stents After PCI : A GRADE-Assessed Systematic Review and Meta-Analysis of Randomised Controlled Trials

Closing Thoughts

Case Discussion

Case Presentation: Outcomes with Bioadaptor in Complex PCI

Case Presentation: Long-Term Follow Up in LAD Disease and Computational Analysis

Panel Discussion: Why Does the MOA of Bioadaptor Matter? Impact on Patients Outcomes in PCI

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content